Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q3 2016 · 10-Q
Revenue$70.49K$70.49K+33.3% vs Q3 2015 Net Income-$644.02K-$644.02KN/M vs Q3 2015 EPS Diluted$0.00$0.00−100.0% vs Q3 2015 Gross Profit$60,562+50.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Operating Cash Flowderived-$419,275N/M Margins · derivedGross margin85.9%+9.6 pt vs Q3 2015
Operating margin-717.9%+6690.4 pt vs Q3 2015
Net margin-913.7%+6535.7 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 22, 2016 · 53 d after period end